EV Biologics, Inc. (YECO)

Market Cap	4.35M
Revenue (ttm)	48,900
Net Income (ttm)	-1.04M
Shares Out	7.23M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	0.602
Previous Close	0.602
Day's Range	0.602 - 0.602
52-Week Range	0.563 - 1.950
Beta	-1.14
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About YECO

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 284
• Stock Exchange: OTCMKTS
• Ticker Symbol: YECO